| 177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours (NCT04375267) | Vastra Gotaland Region | 2020-04-23 |
| A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults (NCT04380701) | BioNTech SE | 2020-04-23 |
| A Study of a Candidate COVID-19 Vaccine (COV001) (NCT04324606) | University of Oxford | 2020-04-23 |
| Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma (NCT04393506) | Shanghai Jiao Tong University School of Medicine | 2020-04-23 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combination With AK104 (NCT04349969) | Akesobio Australia Pty Ltd | 2020-04-23 |
| First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19 (NCT04350736) | Theravance Biopharma | 2020-04-23 |
| Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease. (NCT04362670) | Ocular Therapeutix, Inc. | 2020-04-23 |
| Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels (NCT04537715) | Epizyme, Inc. | 2020-04-23 |
| A Study to Evaluate the Safety, Tolerability and How YH002 Enters, Moves Through and Exits the Body in Subjects With Advanced Solid Malignancies (NCT04353102) | Eucure (Beijing) Biopharma Co., Ltd | 2020-04-22 |
| Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors (NCT04374877) | Coherus Oncology, Inc. | 2020-04-22 |
| A Personalized NeoAntigen Cancer Vaccine Combined With Anti-PD-1 in Melanoma (NCT04072900) | Xiangya Hospital of Central South University | 2020-04-21 |
| A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors (NCT05602792) | ImmVira Pharma Co. Ltd | 2020-04-21 |
| BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I) (NCT04018248) | Boryung Pharmaceutical Co., Ltd | 2020-04-21 |
| A Study to Assess YH001 in Combination With Toripalimab Injection in Subjects With Advanced Solid Tumors (NCT04357756) | Eucure (Beijing) Biopharma Co., Ltd | 2020-04-21 |
| MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy. (NCT05877651) | HRYZ Biotech Co. | 2020-04-21 |
| ImmunoBreast - A Phase Ib Study (NCT04609215) | Henrik Ditzel | 2020-04-21 |
| DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma (NCT04248569) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-04-20 |
| MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients (NCT04212221) | Zai Lab (Shanghai) Co., Ltd. | 2020-04-20 |
| ASC Therapy for Patients With Severe Respiratory COVID-19 (NCT04341610) | Rigshospitalet, Denmark | 2020-04-20 |
| High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19 (NCT04351620) | University of Chicago | 2020-04-20 |
| Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema (NCT04378569) | Arcutis Biotherapeutics, Inc. | 2020-04-20 |
| Clinical Application of Methylene Blue for Treatment of Covid-19 Patients (NCT04370288) | Mashhad University of Medical Sciences | 2020-04-19 |
| Safety and Pharmacokinetics Study of MT-3921 in Spinal Cord Injury (NCT04096950) | Tanabe Pharma America, Inc. | 2020-04-19 |
| An Ascending, Multiple-Dose, Safety and Tolerability Study of Tecarfarin in Healthy Chinese Volunteers (NCT04627116) | Lee's Pharmaceutical Limited | 2020-04-19 |
| Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management (NCT04343092) | University of Baghdad | 2020-04-18 |
| A Trial of SHR3162 in Healthy Caucasian Volunteers (NCT04333134) | Atridia Pty Ltd. | 2020-04-17 |
| Safety and Pharmacokinetics of Ceftolozane/Tazobactam in Pediatric Participants With Nosocomial Pneumonia (MK-7625A-036) (NCT04223752) | Merck Sharp & Dohme LLC | 2020-04-17 |
| Study Testing Convalescent Plasma vs Best Supportive Care (NCT04333251) | Baylor Research Institute | 2020-04-17 |
| A Study of SI-B001, an EGFR/HER3 Bispecific Antibody, in Locally Advanced or Metastatic Epithelial Tumors (NCT04603287) | Sichuan Baili Pharmaceutical Co., Ltd. | 2020-04-17 |
| Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathy (NCT04238793) | Kolon Life Science | 2020-04-16 |
| Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate Cancer (NCT04279561) | Jonsson Comprehensive Cancer Center | 2020-04-16 |
| Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 (NCT04344457) | Perseverance Research Center, LLC | 2020-04-16 |
| Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation (NCT04357782) | Hunter Holmes Mcguire Veteran Affairs Medical Center | 2020-04-16 |
| Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) (NCT04352608) | Sinovac Research and Development Co., Ltd. | 2020-04-16 |
| MSC Infusion for Anti-aging and Regenerative Therapy (NCT04174898) | Landmark Medical Centre Sdn Bhd | 2020-04-15 |
| Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease (NCT04509219) | Chang Gung Memorial Hospital | 2020-04-15 |
| Single Dose Mass Balance Study With [14C]Iruplinalkib (WX-0593) In Healthy Male Volunteers (NCT05716126) | Qilu Pharmaceutical Co., Ltd. | 2020-04-15 |
| CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer (NCT04310774) | Peking Union Medical College Hospital | 2020-04-15 |
| Evaluation of RC28-E Injection in Wet Age-related Macular Degeneration (NCT04270669) | RemeGen Co., Ltd. | 2020-04-15 |
| CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR) (NCT03774654) | Baylor College of Medicine | 2020-04-14 |
| Ketorolac vs Oxycodone for Great Toe Arthrodesis (NCT05054868) | Medstar Health Research Institute | 2020-04-14 |
| A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes (NCT04378920) | Institut de cancérologie Strasbourg Europe | 2020-04-14 |
| A Study to Assess 18-Methoxycoronaridine (18-MC HCl) in Healthy Volunteers (NCT04292197) | Definium Therapeutics US, Inc. | 2020-04-14 |
| Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial (NCT04339504) | Medipost Co Ltd. | 2020-04-14 |
| A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors (NCT04175847) | RemeGen Co., Ltd. | 2020-04-14 |
| Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19 (NCT04435808) | University of New Mexico | 2020-04-14 |
| PT-112 (Phosplatin's Platinum) Combine With Gemcitabine Injection for Advanced Solid Tumors (NCT05357196) | SciClone Pharmaceuticals | 2020-04-13 |
| AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma (NCT04368182) | Zhejiang University | 2020-04-13 |
| A Drug-drug Interaction Trial of Loperamide Pharmacokinetics Effect on Pyrotinib Maleate (NCT04315116) | Jiangsu HengRui Medicine Co., Ltd. | 2020-04-13 |
| A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NCT04281420) | Antengene Therapeutics Limited | 2020-04-13 |
| Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001) (NCT04184050) | Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2020-04-13 |
| Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease (NCT04617847) | Wave Life Sciences USA, Inc. | 2020-04-13 |
| Nivolumab for High-Risk MDS/AML Patients After Allogeneic Stem Cell Transplant With Post-Transplant Cyclophosphamide (NCT04361058) | SCRI Development Innovations, LLC | 2020-04-13 |
| Hydroxychloroquine in Outpatient Adults With COVID-19 (NCT04333654) | Sanofi | 2020-04-12 |
| Bioequivalence Study Between YHP1906 Tab. 5 mg and YHR1902 Tab. 5 mg (NCT04316065) | Yuhan Corporation | 2020-04-11 |
| Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19) (NCT04390178) | Joakim Dillner | 2020-04-10 |
| A Study of TQB3455 Tablets in Subjects With Advanced Malignancies (NCT04340427) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-04-10 |
| COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers (NCT04392219) | Ridgeback Biotherapeutics, LP | 2020-04-10 |
| Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus (NCT04441658) | Shanghai East Hospital | 2020-04-10 |
| Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors (NCT04284488) | Ascentage Pharma Group Inc. | 2020-04-10 |
| Study to Evaluate the Safety and Pharmacokinetics of Single-Dose Fluzoparib in Healthy Chinese Subjects (NCT04341077) | Jiangsu HengRui Medicine Co., Ltd. | 2020-04-10 |
| Intratumoral Tilsotolimod, a TLR-9 Agonist, Together With Intratumoral Ipilimumab and Intravenous Nivolumab in Patients With Advanced Cancers (NCT04270864) | Gustave Roussy, Cancer Campus, Grand Paris | 2020-04-10 |
| A Study to Find the MTD of SYN125 in People With Solid Tumors and the MTD of SYN125 With a Fixed Dose of SYN004 in People in Patients With Epithelial Cancers With EGFR Expressions (NCT04363242) | Synermore Biologics Co., Ltd. | 2020-04-09 |
| A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19 (NCT03891420) | BioCryst Pharmaceuticals | 2020-04-09 |
| Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer (NCT03983395) | Ichnos Sciences SA | 2020-04-08 |
| Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy Subjects (NCT04260438) | Chong Kun Dang Pharmaceutical | 2020-04-08 |
| Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer (NCT04120246) | Veana Therapeutics | 2020-04-08 |
| PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers (NCT04209595) | National Cancer Institute (NCI) | 2020-04-08 |
| Convalescent Plasma vs. Standard Plasma for COVID-19 (NCT04344535) | Stony Brook University | 2020-04-08 |
| Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies (NCT04068194) | National Cancer Institute (NCI) | 2020-04-07 |
| A Study to Compare Pharmacokinetic and Safety Profiles of Different Formulations of SHR-1314 After Subcutaneous Injection in Healthy Subjects (NCT04326881) | Jiangsu HengRui Medicine Co., Ltd. | 2020-04-07 |
| Baricitinib for the Prophylaxis of Graft-Versus-Host Disease After Peripheral Blood Hematopoietic Cell Transplantation (NCT04131738) | Washington University School of Medicine | 2020-04-07 |
| Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2) (NCT04330664) | Mirati Therapeutics Inc. | 2020-04-07 |
| Study to Assess AFM24 in Advanced Solid Cancers (NCT04259450) | Affimed GmbH | 2020-04-07 |
| A Study to Determine Safety and Efficacy of (REMD-477) in Controlling Hyperglycemia Due to Copanlisib (NCT04253223) | Duke University | 2020-04-07 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of SYHA1801 Monotherapy in Patients With Advanced Solid Tumors (NCT04309968) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-04-07 |
| Intermediate IND Severe Illness COVID-19 CP (NCT04411602) | Henry Ford Health System | 2020-04-07 |
| MM-398 and Ramucirumab in Treating Patients With Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (NCT03739801) | University of Southern California | 2020-04-06 |
| Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS (NCT04333368) | Assistance Publique - Hôpitaux de Paris | 2020-04-06 |
| Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer (NCT04337970) | Memorial Sloan Kettering Cancer Center | 2020-04-06 |
| Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389 (NCT04322032) | Chong Kun Dang Pharmaceutical | 2020-04-06 |
| Trial for Relapsed or Refractory AML Patients Combining Cytarabine and Mitoxantrone With Venetoclax (RELAX) (NCT04330820) | Technische Universität Dresden | 2020-04-06 |
| Study of Open Label Losartan in COVID-19 (NCT04335123) | University of Kansas Medical Center | 2020-04-04 |
| Chidamide in Combination With Decitabine in Non-Hodgkin's Lymphoma Relapsed After Chimeric Antigen Receptor (NCT04337606) | Chinese PLA General Hospital | 2020-04-04 |
| Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19 (NCT04473170) | Abu Dhabi Stem Cells Center | 2020-04-04 |
| The Impact of Camostat Mesilate on COVID-19 Infection (NCT04321096) | University of Aarhus | 2020-04-04 |
| A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer (NCT04253262) | Brown University | 2020-04-03 |
| Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers (NCT04336410) | Inovio Pharmaceuticals | 2020-04-03 |
| Isatuximab, Bendamustine, and Prednisone in Refractory Multiple Myeloma (NCT04083898) | Washington University School of Medicine | 2020-04-03 |
| A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tumors (NCT04413227) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2020-04-02 |
| A PK Similarity Study of Two Sintilimab Products Produced by Different Processes in Advanced or Metastatic NSCLC Patients (NCT04177290) | Innovent Biologics (Suzhou) Co. Ltd. | 2020-04-02 |
| Trial of Safety, Tolerability and Efficacy of Trametinib (SNR1611) in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT04326283) | Genuv Inc. | 2020-04-02 |
| Ascending Single-dose Study to Evaluate TVB-2640 in Chinese Healthy Subjects (NCT04352361) | Ascletis Pharmaceuticals Co., Ltd. | 2020-04-02 |
| MitoQ for Fatigue in Multiple Sclerosis (MS) (NCT04267926) | VA Office of Research and Development | 2020-04-01 |
| The Effect of SOW Mouthwash on the Level of IL_1β in GCF and Some Clinical Periodontal Parameters for Patients With Gingivitis (NCT04328753) | University of Baghdad | 2020-04-01 |
| Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer (NCT04134884) | Kathy Miller | 2020-04-01 |
| A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer (NCT04288089) | Eisai Inc. | 2020-04-01 |
| Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial (NCT03878524) | OHSU Knight Cancer Institute | 2020-04-01 |
| Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19) (NCT04346368) | Guangzhou Institute of Respiratory Disease | 2020-04-01 |
| Can Intensive Insulin Therapy Improve Outcomes of COVID-19 Patients (NCT05441631) | Benha University | 2020-04-01 |